Skip to main content
Premium Trial:

Request an Annual Quote

Open Access Goes to Washington

Publishers and open-access advocates are duking it out in front of a US House of Representatives committee, reports the Chronicle of Higher Education's Jennifer Howard. The fight is over whether research paid for with federal money should be made publically accessible. Advocates say yes, but publishers are urging lawmakers not to make a hasty decision, "for fear of putting US intellectual property — and publishers' livelihoods — at risk," Howard says. The measures advocates are fighting for include initiatives like NIH's policy requiring results of federally-funded research be made openly available within 12 months of publication, she adds.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.